These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Frederick L; Wang XY; Eley G; James CD Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703 [TBL] [Abstract][Full Text] [Related]
3. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092 [TBL] [Abstract][Full Text] [Related]
7. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678 [TBL] [Abstract][Full Text] [Related]
8. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma. Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063 [TBL] [Abstract][Full Text] [Related]
9. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454 [TBL] [Abstract][Full Text] [Related]
11. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Reinmuth N; Jauch A; Xu EC; Muley T; Granzow M; Hoffmann H; Dienemann H; Herpel E; Schnabel PA; Herth FJ; Gottschling S; Lahm H; Steins M; Thomas M; Meister M Lung Cancer; 2008 Nov; 62(2):193-201. PubMed ID: 18450321 [TBL] [Abstract][Full Text] [Related]
12. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method. Miyanaga T; Hirato J; Nakazato Y Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group. Chakravarti A; Seiferheld W; Tu X; Wang H; Zhang HZ; Ang KK; Hammond E; Curran W; Mehta M Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):318-27. PubMed ID: 15890570 [TBL] [Abstract][Full Text] [Related]
14. EGFR tyrosine kinase domain mutations in human gliomas. Marie Y; Carpentier AF; Omuro AM; Sanson M; Thillet J; Hoang-Xuan K; Delattre JY Neurology; 2005 Apr; 64(8):1444-5. PubMed ID: 15851741 [TBL] [Abstract][Full Text] [Related]
15. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course. Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673 [TBL] [Abstract][Full Text] [Related]
16. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Na II; Kang HJ; Cho SY; Koh JS; Lee JK; Lee BC; Lee GH; Lee YS; Yoo HJ; Ryoo BY; Yang SH; Shim YS Eur J Cancer; 2007 Feb; 43(3):520-6. PubMed ID: 17224267 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Ekstrand AJ; Longo N; Hamid ML; Olson JJ; Liu L; Collins VP; James CD Oncogene; 1994 Aug; 9(8):2313-20. PubMed ID: 8036013 [TBL] [Abstract][Full Text] [Related]
18. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer. Cho KS; Lee JS; Cho NH; Park K; Ham WS; Choi YD Prostate; 2008 Jun; 68(8):803-8. PubMed ID: 18302229 [TBL] [Abstract][Full Text] [Related]
19. The EGFRvIII variant in glioblastoma multiforme. Gan HK; Kaye AH; Luwor RB J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552 [TBL] [Abstract][Full Text] [Related]